1-4 of 4
Martin Schuler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ceritinib in patients with advanced anaplastic lymphoma kinase–rearranged anaplastic large-cell lymphoma

Clinical Trials & Observations
Heike Richly, Tae Min Kim, Martin Schuler, Dong-Wan Kim, Simon J. Harrison, Alice T. Shaw, Anthony L. Boral, Alejandro Yovine, Benjamin Solomon
Journal: Blood
Blood (2015) 126 (10): 1257–1258.
https://doi.org/10.1182/blood-2014-12-617779
Published: 2015
Journal Articles

Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis

Claudia Stolz, Georg Hess, Patricia S. Hähnel, Florian Grabellus, Sandra Hoffarth, Kurt W. Schmid, Martin Schuler
Journal: Blood
Blood (2008) 112 (8): 3312–3321.
https://doi.org/10.1182/blood-2007-11-124487
Published: 2008
Includes: Supplemental data
Journal Articles

An immune escape screen reveals Cdc42 as regulator of cancer susceptibility to lymphocyte-mediated tumor suppression

Celio A. Marques, Patricia S. Hähnel, Catherine Wölfel, Sonja Thaler, Christoph Huber, Matthias Theobald, Martin Schuler
Journal: Blood
Blood (2008) 111 (3): 1413–1419.
https://doi.org/10.1182/blood-2007-05-089458
Published: 2008
Includes: Supplemental data
Journal Articles

Graft-Versus-Host Disease or Infection: Rapid Detection of HLA Mismatch-Reactive T Cells Ex Vivo Can Facilitate Diagnosis and Guide Therapy after Allogeneic Transplantation.

Eva Distler, Simone Thomas, Elke Schuerer, Cedrik Britten, Martin Schuler, Christoph Huber, Karin Kolbe, Thomas Woelfel, Ralf Meyer, Wolfgang Herr
Journal: Blood
Blood (2007) 110 (11): 4993.
https://doi.org/10.1182/blood.V110.11.4993.4993
Published: 2007